<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lederman, Lynne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Kuritzkes, Daniel</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Curing HIV-1 Infection Remains an Elusive Goal</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">32-33</style></pages><abstract><style  face="normal" font="default" size="100%">Although current antiretroviral therapy (ART) for human immunodeficiency virus (HIV) successfully controls infection and reduces mortality, curing infection is an important goal. This article reviews the cases of patients who might be appropriate candidates for an attempt at curing HIV infection, elite controllers, the role of HIV reservoirs, and the development of therapeutic vaccines to cure HIV infection.</style></abstract><number><style face="normal" font="default" size="100%">28</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>